Abstract
Development of biologic therapies for severe asthma and increased focus on patient priorities warrant reassessment of outcomes used in asthma clinical studies. Building consensus on a core outcome set (COS) by engaging patients and other key stakeholders helps to ensure high-priority outcomes are consistent in clinical study designs. Strategies to amplify the patient voice and incorporate patient perspectives must be applied.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
